The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Main Authors: | , , , , , , |
|---|---|
| Drugi avtorji: | |
| Format: | Conference item |
| Jezik: | English |
| Izdano: |
Elsevier
2020
|